Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial

The risk for and treatment of cardiovascular disease (CVD) in type 2 diabetes (T2DM) is often incorrect and delayed. We wished to determine if a novel test improved physicians ’ ability to risk stratify, diagno...

Source: Diabetology and Metabolic Syndrome - July 13, 2023 Category: Endocrinology Authors: John W. Peabody, David Paculdo, Enrico de Belen, Divya Ganesan, Isabella Cooney and Nelson Trujillo Tags: Research Source Type: research